Pascal Schneider
Impact in
- Immunology top 0.02%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- interferon and immune responses
- Cancer Research top 0.1%
- NF-κB Signaling Pathways
Papers in
-
- Cell death mechanisms and regulation 36
- dental development and anomalies 33
- Immunology 121
- Immune Cell Function and Interaction 54
- T-cell and B-cell Immunology 51
- Immune Response and Inflammation 29
- Immunotherapy and Immune Responses 28
- Co-authors
- Jürg Tschopp (40 shared papers)Fabienne Mackay (19 shared papers)Jean-Luc Bodmer (14 shared papers)Nils Holler (14 shared papers)Margot Thome (9 shared papers)Jeffrey L. Browning (9 shared papers)Kay Hofmann (10 shared papers)Lars E. French (7 shared papers)
- Journals
- Journal of Biological Chemistry (25 papers)The Journal of Experimental Medicine (14 papers)The Journal of Immunology (10 papers)European Journal of Immunology (8 papers)Proceedings of the National Academy of Sciences (8 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Pascal Schneider
256 papers receiving 33.2k citations
Pascal Schneider's Hit Papers
Peers
Comparison fields: 5 of 145
- Immunology 16.0k
- Cancer Research 4.5k
- Molecular Biology 14.4k
- Immunology and Allergy 1.1k
- Rheumatology 2.6k
Countries citing papers authored by Pascal Schneider
This map shows the geographic impact of Pascal Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Schneider more than expected).
Fields of papers citing papers by Pascal Schneider
This network shows the impact of papers produced by Pascal Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Schneider. The network helps show where Pascal Schneider may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Schneider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 261 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of death receptor signals by cellular FLIP Hit paper breakdown → | 1997 | 2122 |
| 2 | Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule Hit paper breakdown → | 2000 | 1550 |
| 3 | Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations Hit paper breakdown → | 1999 | 1192 |
| 4 | BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth Hit paper breakdown → | 1999 | 1110 |
| 5 | Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors Hit paper breakdown → | 1997 | 1066 |
| 6 | Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape Hit paper breakdown → | 1996 | 1052 |
| 7 | IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis Hit paper breakdown → | 2007 | 880 |
| 8 | BAFF and APRIL: A Tutorial on B Cell Survival Hit paper breakdown → | 2003 | 789 |
| 9 | BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF Hit paper breakdown → | 2001 | 754 |
| 10 | Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin Hit paper breakdown → | 1998 | 737 |
| 11 | Cracking the BAFF code Hit paper breakdown → | 2009 | 728 |
| 12 | The molecular architecture of the TNF superfamily Hit paper breakdown → | 2002 | 710 |
| 13 | Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity Hit paper breakdown → | 1998 | 689 |
| 14 | Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome Hit paper breakdown → | 2002 | 683 |
| 15 | TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB Hit paper breakdown → | 1997 | 606 |
| 16 | Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome Hit paper breakdown → | 2002 | 601 |
| 17 | Baff Mediates Survival of Peripheral Immature B Lymphocytes Hit paper breakdown → | 2000 | 579 |
| 18 | TRAIL receptor-2 signals apoptosis through FADD and caspase-8 Hit paper breakdown → | 2000 | 566 |
| 19 | MyD88, an Adapter Protein Involved in Interleukin-1 Signaling Hit paper breakdown → | 1998 | 533 |
| 20 | 2005 | 479 |
About Pascal Schneider
Pascal Schneider is a scholar working on Molecular Biology, Immunology, Cancer Research, Epidemiology and Oncology, having authored 261 papers that have together received 33.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (54 papers), T-cell and B-cell Immunology (51 papers), NF-κB Signaling Pathways (42 papers), Cell death mechanisms and regulation (36 papers), dental development and anomalies (33 papers), Immune Response and Inflammation (29 papers), Immunotherapy and Immune Responses (28 papers) and Cell Adhesion Molecules Research (18 papers). The work is most often cited by research in Immunology (16.0k citations), Cancer Research (4.5k citations), Molecular Biology (14.4k citations), Immunology and Allergy (1.1k citations) and Rheumatology (2.6k citations). Pascal Schneider has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Jürg Tschopp, Fabienne Mackay, Jean-Luc Bodmer, Nils Holler, Margot Thome, Jeffrey L. Browning, Kay Hofmann, Lars E. French, Michael Hahne and Michael Schröter. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine, The Journal of Immunology, European Journal of Immunology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.